Pharmaceutical R&D Intelligence
Pharma R&D Annual Review 2010
May is the time when Citeline Drug Intelligence's Annual Review of trends in pharmaceutical R&D is traditionally conducted. It is a useful opportunity to pause and reflect on the how the industry is continuing to evolve, and is also the time when we take the annual snapshot our data which provides a new timepoint for our Trends data module in one of our database products, Pharmaprojects. In this article, we examine the data for 2010, look at how it has changed since 2009, and try to put the information into some sort of context.
Additionally, as Pharmaprojects celebrates its 30th birthday, we look briefly at the seismic shifts which have occurred in both the pharma industry and the way it shares information on its activities with the wider world. In tracking pharma R&D for the last three decades, we are ideally placed to observe not only the changes in the way in which drugs are developed and the size and shapes of R&D pipelines, but also the extraordinary information revolution which has so greatly affected all of our lives....
Mergers, Acquistions & Joint Ventures
- Nordic Bioscience has acquired Sanos Bioscience.
- Genzyme has been acquired by Sanofi-Aventis.
- Calistoga Pharmaceuticals has been acquired by Gilead Sciences.
New Drug Targets
Newly identified drug protein targets.
